Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT03349502
Eligibility Criteria:
Inclusion Criteria:
* Age between 18 to 65
* Eastern Cooperative Oncology Group (ECOG) performance status 0,1,2
* Informed consent
* Diagnosed with acute myeloid leukemia by 2016 WHO criteria
* Failure to achieve complete remission after the second line of standard chemotherapy
* Relapse after the second line of standard chemotherapy and not eligible for the allogeneic stem cell transplantation
* Adequate major organ function
Exclusion Criteria:
* Acute promyelocytic leukemia
* Central nervous system involvement of the leukemia
* Hypersensitivity to IL-2
* Previous cell therapy
* Impaired major organ function
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT03349502
Study Brief:
Protocol Section:
NCT03349502